Psychiatric disorders in smokers seeking treatment for tobacco dependence: Relations with tobacco dependence and cessation.

• DOI: 10.1037/a0018065
• Publication Date: 2010-01-26T15:29:40Z
• Authors: Megan E. Piper; Stevens S. Smith; Tanya R. Schlam; Michael F. Fleming; Amy A. Bittrich; Jennifer L. Brown; Cathlyn J. Leitzke; Mark E. Zehner; Michael C. Fiore; Timothy B. Baker
• Keywords: Adult; Male; Psychiatric Status Rating Scales; Motivation; Nicotine; Mood Disorders; Patient Selection; Smoking; Tobacco Use Disorder; Middle Aged; Anxiety Disorders; 3. Good health; 03 medical and health sciences; Treatment Outcome; 0302 clinical medicine; Double-Blind Method; Surveys and Questionnaires; Humans; Regression Analysis; Female; Smoking Cessation

Objective-The present research examined the relation of psychiatric disorders to tobacco dependence and cessation outcomes.Method-Data were collected from 1504 smokers (58.2% women, 83.9% white, 44.67 [SD = 11.08] years old) making an aided smoking attempt as part a clinical trial.Psychiatric diagnoses determined using Composite International Diagnostic Interview (CIDI) structured interview.Tobacco was assessed Fagerstrom Test Nicotine Dependence (FTND) Wisconsin Inventory Smoking Motives (WISDM).Results-Diagnostic groups included those who never diagnosed, ever diagnosed (at any time, including in past year), with past-year (with or without prior diagnosis).Some diagnostic had lower follow-up abstinence rates than did group (p's < .05).At 8 weeks post-quit, strong associations found between outcome both mood disorder ever-diagnosed anxiety disorder.At 6 months post-quit (OR .72,p .02)and more one diagnosis .74,p .03)had rates.The categories not differ heaviness FTND, but they motives WISDM. Conclusion-Informationon recent lifetime may help clinicians gauge relapse risk suggest that are particularly relevant affected patients.These findings also illustrate importance multidimensional assessments.